Procter & Gamble Company

Procter & Gamble closed near the top of its 52-week range, with the stock hovering around $165. The company trades at 20.4 times earnings, a premium that reflects its 19.2% net margin and steady 8.6% EPS growth. Revenue rose 3.3% year over year, a modest clip for a consumer staple, but the margin story keeps the valuation intact. The Alpha Score sits at 54.7, lifted by a quality sub-score of 63.3. Momentum and value are middling — 52.2 and 53, respectively — while sentiment sits at exactly 50. That neutral sentiment reading suggests the market has priced in the known: steady demand, input cost discipline, and a strong balance sheet. What to watch next week: any consumer spending data that could signal whether the staple sector's defensive premium holds. PG's earnings are due in late July, and the bar for margin expansion is high after two quarters of beats.

Procter & Gamble sits near the middle of its 52-week range after a quiet session. The stock carries a 20.4 P/E on $6.84 in trailing EPS, with net margins holding above 19%. Revenue grew 3.3% year over year, while EPS expanded faster at 8.6%, helped by cost cuts and pricing. The Alpha Score of 54.8 is driven by quality at 63.3, with momentum and value both near 52-53. Sentiment is neutral at 50. What to watch: the next quarterly print will show whether volume growth can keep pace with input inflation. If margins hold, the stock stays in its current range. A miss on volume would test the $138 support.

Procter & Gamble sits near the top of its 52-week range, supported by a 63.3 quality sub-score that tops its Alpha Score components. The stock's P/E of 20.39 is a premium to the consumer staples sector median, but the 19.2% net margin and 8.6% EPS growth provide cover. Revenue growth of 3.3% is modest — the company is not a top-line story — but the margin expansion and share buyback tailwind have been the drivers. The 52W range of $138 to $167 is wide; the stock is now roughly $15 off the high, a gap that could close if the next quarterly print shows another beat-and-raise. Momentum sits at 52.3, not screaming, but the trend is intact. The value score is near neutral at 53, meaning the multiple is fair relative to historicals. Watch for the next earnings release, likely in late July, for any shift in the organic sales growth trajectory. If the consumer holds up, PG's defensive appeal keeps the floor firm.

Procter & Gamble settled at $150.72 Wednesday, holding near the midpoint of a 52-week range that runs from $137.62 to $167.25. The stock carries a P/E of 20.25 on trailing EPS of $6.84, with net margins of 19.2% and revenue growth of 3.3% year-over-year. The Alpha Score sits at 55.7, driven by a quality sub-score of 63.3 that reflects consistent earnings generation. EPS grew 8.6% over the past year, outpacing revenue growth by a wide margin — margin expansion doing the heavy lifting. Momentum at 55 and value at 53.6 are middling, suggesting the market has priced steady performance without enthusiasm. PureCycle's revenue miss raised questions about recycling economics, but PG's ownership stake is small and its core business remains insulated from that technology ramp. The consumer staples sector is seeing flat shelves at U.S. grocers, with PG's volume trends mixed — fabric care flat, baby care slightly negative. What to watch: second-half guidance from management and whether PG can hold above $148, the 200-day moving average. The next catalyst is the July 30 earnings print.

Procter & Gamble sits at $165.20, just $2 off its 52-week high of $167.25. The stock has crept higher through a quiet stretch for staples, with the consumer sector broadly flat over the past month. PG's Alpha Score of 54 is driven by a quality sub-score of 63.3, reflecting net margins above 19% and steady EPS growth of 8.6% year over year. Revenue growth is softer at 3.3%, which keeps the value score at 53.6 and momentum at 49.2. The P/E of 20.25 is a touch above the sector median, but the earnings trajectory has held. What to watch: the next quarterly print, due in late April, will test whether volume growth can keep pace with the price increases that have carried revenue so far.